Research Article
A Double-Blind, Randomized, Crossover Comparative Study for Evaluating the Clinical Safety of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE)
Table 2
Baseline characteristics of subjects, vital signs, and hematological findings.
| n | All Subjects | EHE-P | EFE-P | 12 | 6 | 6 |
| Age, years | 35.4±7.9 | 36.5±9.7 | 34.3±6.5 | Height, cm | 172.7±5.0 | 174.1±6.1 | 171.3±3.5 | Weight, kg | 62.2±5.3 | 61.2±6.9 | 63.3±3.3 | Body temperature, °C | 36.5±0.3 | 36.5±0.3 | 36.5±0.3 | Systolic blood pressure, mmHg | 113.7±6.9 | 111.8±7.4 | 115.5±6.5 | Diastolic blood pressure, mmHg | 72.5±7.7 | 70.8±8.5 | 74.2±7.2 | Pulse rate, /min | 70.7±10.6 | 71.8±10.5 | 69.5±11.6 | White blood cell count, /× 1000 μL | 4.1±1.0 | 4.5±1.0 | 3.6±0.8 | Hemoglobin level, g/dl | 14.1±0.7 | 13.9±0.7 | 14.4±0.6 | Blood platelet count, ×103/μL | 227±55 | 238±68 | 217±42 |
|
|
EHE-P: prior administration of EHE group; EFE-P: prior administration of EFE group
|